Drug Discovery techonogy Market Report 2024: Growth Rate, Major Segments And Regions

saikiran TBRC

Drug Discovery techonogy Market Report 2024: Growth Rate, Major Segments And Regions

The Artificial Intelligence (AI) In Drug Discovery by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Artificial Intelligence (AI) In Drug Discovery Market:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

According to The Business Research Company’s Artificial Intelligence (AI) In Drug Discovery, The artificial intelligence (ai) in drug discovery market size has grown exponentially in recent years. It will grow from $1.37 billion in 2023 to $1.79 billion in 2024 at a compound annual growth rate (CAGR) of 30.8%. The growth in the historic period can be attributed to growth in emerging markets, the rising prevalence of chronic diseases, the increased adoption of artificial intelligence (ai) for cost efficient drug discovery and the increasing strict quality regulations for drug manufacturers.

The artificial intelligence (ai) in drug discovery market size is expected to see exponential growth in the next few years. It will grow to $4.71 billion in 2028 at a compound annual growth rate (CAGR) of 27.4%. The growth in the forecast period can be attributed to the government support, the increasing healthcare expenditure and rising adoption of cloud-based applications and services. Major trends in the forecast period include integration of multi-omics data, use of ai in target selection, use of ai in drug screening, introduction of ai innovation labs, increasing investments and partnerships and collaborations.

The growing demand for personalized medicine is expected to propel the growth of the artificial intelligence (AI) in drug discovery market going forward. Personalized medicine refers to a type of medication that prevents, detects, or treats disease using knowledge about a person's own genes or proteins. AI can play a crucial role in the development of personalized medicines at all relevant phases of clinical development and implementation of new personalized health products by finding appropriate intervention targets and testing intervention targets for their utility. For instance, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the US Food and Drug Administration (FDA) approved 12 personalized medicines, which accounted for approximately 34% of all newly approved therapeutic molecular entities. Thus, the growing demand for personalized medicine is driving the growth of the artificial intelligence (AI) in drug discovery market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

The artificial intelligence (ai) in drug discovery market covered in this report is segmented –

1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

2) By Drug Type: Small Molecules, Large Molecules

3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics

4) By End User: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users

Major companies operating in the AI drug delivery market are adopting strategic collaborations to research and discover drugs using AI and are gaining significant popularity in the artificial intelligence in drug discovery market. For instance, in August 2022, Atomwise, a US-based artificial intelligence systems company, partnered with Sanofi. The partnership aimed at computationally identifying and investigating up to five pharmacological targets using the Atomwise AI-powered AtomNet technology. To find, create, and advance lead compounds for up to five Sanofi-exclusive targets, Atomwise received a $20 million upfront payment from Sanofi. Sanofi is a French pharmaceutical and healthcare company.

The artificial intelligence (ai) in drug discovery market report table of contents includes:

1. Executive Summary

2. Artificial Intelligence (AI) In Drug Discovery Market Characteristics

3.Artificial Intelligence (AI) In Drug Discovery Market Trends And Strategies

4.Artificial Intelligence (AI) In Drug Discovery Market analysis

5.Artificial Intelligence (AI) In Drug Discovery Market Size And Growth

6.Artificial Intelligence (AI) In Drug Discovery Segmentation

7.Artificial Intelligence (AI) In Drug Discovery Regional And Country Analysis

27. Artificial Intelligence (AI) In Drug Discovery Competitive Landscape And Company Profiles

28.Artificial Intelligence (AI) In Drug Discovery Key Mergers And Acquisitions

29.Artificial Intelligence (AI) In Drug Discovery Future Outlook and Potential Analysis

TOP MAJOR PLAYERS:

IBM Corporation
Microsoft Corporation
NVIDIA Corporation
Exscientia
Alphabet
Atomwise Inc.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

saikiran TBRC

Artificial Intelligence (AI) In Drug Discovery Market 2022 - Estimated Yield, Demand And Revenue Analysis

Biswadeep 2022-05-09

id=3411&type=smp The global artificial intelligence in drug discovery market size is expected to grow from $0. com/report/artificial-intelligence-in-drug-discovery-global-market-report The Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022-31 by The Business Research Company evaluates artificial intelligence in drug discovery market size, growth rate, drivers, artificial intelligence in drug discovery industry trends, and major companies. Impact Of COVID-19 On Artificial Intelligence (AI) In Drug Discovery Market5. Key Mergers And Acquisitions Of The Artificial Intelligence (AI) In Drug Discovery Market 29. Future Outlook and Potential Analysis Of The Artificial Intelligence (AI) In Drug Discovery Market About The Business Research Company: The Business Research Company is a market intelligence firm that excels in company, market, and consumer research.

Jignesh Jariwala 2022-09-23

has added a new report titled, ‘Artificial Intelligence ( AI ) in Drug Discovery Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecasts, 2022 - 2027’ to its vast repository of research reports. The global Artificial Intelligence ( AI ) in Drug Discovery market was estimated at USD 0. Companies covered:Some of the key players in AI in Drug Discovery Market are Microsoft Corporation (US), Exscientia (UK), NVIDIA Corporation (US), Schrödinger (US), Atomwise, Inc. id=151193446The study categorizes the AI in drug discovery market into the following segments and subsegments:AI in drug discovery market, By Offering· Software· ServicesAI in drug discovery market, By Technology· Machine Learning· Deep Learning· Supervised Learning· Reinforcement Learning· Unsupervised Learning· Other Machine Learning Technologies· Other TechnologiesAI in drug discovery market, by Application· Immuno-oncology· Neurodegenerative diseases· Cardiovascular diseases· Metabolic diseases· Other ApplicationsAI in drug discovery market, By End User· Pharmaceutical & biotechnology companies· Contract research organizations· Research centers and academic & government institutesSome of the key geographies mentioned in this report include:· North America (U. S and Canada and rest of North America)· Europe (Germany, France, Italy, and Rest of Europe)· Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific)· LAMEA (Brazil, Turkey, Saudi Arabia, South Africa, and Rest of LAMEA)Key questions answered in the report· What will be the market size and growth rate by the end of the forecast period?

Artificial Intelligence (Ai) In Drug Discovery Market 2022 Global Share, Size, Business Growth, Trend, and Forecast to 2029

Data Bridge Market Research 2022-05-09

The latest study released on the Global Artificial Intelligence (Ai) In Drug Discovery Market by Data Bridge Market Research evaluates market size, trend, and forecast to 2029. Data Bridge Market Research analyses that the artificial intelligence (AI) in drug discovery market is expected to reach the value of USD 7,818. -To estimate the market shares of major segments of the Artificial Intelligence (Ai) In Drug Discovery-To showcase the development of the Artificial Intelligence (Ai) In Drug Discovery market in different parts of the world. Key Points Covered in Artificial Intelligence (Ai) In Drug Discovery Market Report:Artificial Intelligence (Ai) In Drug Discovery Overview, Definition and Classification Market drivers and barriersArtificial Intelligence (Ai) In Drug Discovery Market Competition by ManufacturersImpact Analysis of COVID-19 on Artificial Intelligence (Ai) In Drug Discovery MarketArtificial Intelligence (Ai) In Drug Discovery Capacity, Production, Revenue (Value) by Region (2021-2027)Artificial Intelligence (Ai) In Drug Discovery Supply (Production), Consumption, Export, Import by Region (2021-2027)Artificial Intelligence (Ai) In Drug Discovery Market Analysis by Application {Enterprise, Individual, Other,}Artificial Intelligence (Ai) In Drug Discovery Manufacturers Profiles/Analysis Artificial Intelligence (Ai) In Drug Discovery Manufacturing Cost Analysis, Industrial/Supply Chain Analysis, Sourcing Strategy and Downstream Buyers, MarketingStrategy by Key Manufacturers/Players, Connected Distributors/Traders Standardization, Regulatory and collaborative initiatives, Industry road map and value chain Market Effect Factors Analysis. What is the impact analysis of various factors in the Global Artificial Intelligence (Ai) In Drug Discovery market growth?

AI for Drug Discovery Market Size, Status, Top Emerging Trends, Growth and Business Opportunities 2027

Fairfield Market Research 2022-06-08

While deepening AI penetration has been unlocking opportunities in disease diagnosis, and treatment, it has also been clearing its way in drug discovery. Fairfield Market Research intends to analyse the growth prospects of the application of AI for drug discovery and estimates the global revenue of the same to reach beyond US$1. While this reveals a drastically reduced time frame involved in the application of AI for drug discovery, there has been a constantly growing series funding in this market over the recent past. Venture capitalists are also stepping into the game, which is further uplifting the growth prospects of global market. Europe will follow with growing adoption of AI in healthcare and drug discovery.

Global Artificial Intelligence (AI) in Drug Discovery Market – Industry Trends and Forecast to 2028.

ava smith 2021-05-22

The global artificial intelligence (AI) in drug discovery market size is expected to reach USD 4.05 billion by 2028 according to a new study by Polaris Market Research.

The report “Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Others); By Application; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Based on therapeutic areas, the global artificial intelligence (AI) in drug discovery market is segmented into oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious diseases, and others.

Cancer treatments vary from person to person and personalized medicine has played an important role.

In this line, a Switzerland-based company, Sophia Genetics developed an AI platform that helps to identify tumors by detecting genetic variations and devising personalized cancer treatment plans.

The increasing adoption of artificial intelligence (AI) platforms in infectious diseases to identify key infection patterns.

Artificial Intelligence in Drug Discovery Market Is Estimated To Witness High Growth Owing To Increasing Adoption of AI in Drug Discovery

Ben Wood 2023-09-12

The global Artificial Intelligence in Drug Discovery Market is estimated to be valued at US$ 1,016. This enables researchers to accelerate the drug discovery process and identify potential drug candidates with higher success rates. PEST Analysis: Political: The political factors affecting the Artificial Intelligence in Drug Discovery Market include government regulations and policies related to drug development and approval. The increasing adoption of AI technologies in the healthcare industry for drug discovery, drug repurposing, and precision medicine is expected to fuel market growth. In terms of regional analysis, North America is anticipated to be the fastest-growing and dominating region in the Artificial Intelligence in Drug Discovery Market.

WHO TO FOLLOW